Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Colorectal Neoplasms

Free Subscription Articles published in Am J Clin Oncol Retrieve available abstracts of 22 articles: HTML format

Single Articles

January 2024
1. TAN C, Wang Q, Yao S
   Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites.
   Am J Clin Oncol. 2024 Jan 22. doi: 10.1097/COC.0000000000001084.
   PubMed     Abstract available
   
   
   
2. LIAO SW, Zhan JQ, Liu CT, Yu HT, et al
   Survival Benefit of Primary Tumor Resection Combined With Chemotherapy in Patients With Unresectable Colorectal Mucinous Adenocarcinoma With Liver Metastasis.
   Am J Clin Oncol. 2024;47:30-39.
   PubMed     Abstract available
   
   
   July 2023
3. NELSON B, Meier T, Zhang Y, Wang K, et al
   Feasibility Trial of Intensity Modulated Proton Therapy to Reduce Toxicity in Anal Cancer Patients.
   Am J Clin Oncol. 2023;46:293-299.
   PubMed     Abstract available
   
   
   May 2023
4. LIN Z, Zheng Y, Yang J, Jin W, et al
   Prognostic Analysis of Lymphovascular Invasion in Stages I-III Colorectal Cancer: A Retrospective Study Based on Propensity Score Match.
   Am J Clin Oncol. 2023 May 23. doi: 10.1097/COC.0000000000001015.
   PubMed     Abstract available
   
   
   April 2023
5. GRACIE J, Fortune EC 4th, Morris CG, Leach DF 3rd, et al
   Radiation Treatment for Cancer of the Anal Margin.
   Am J Clin Oncol. 2023;46:167-171.
   PubMed     Abstract available
   
   
   March 2023
6. HUANG KX, Pan YF, Dai RS, Xu LS, et al
   A Preliminary Study of Immediate Intraperitoneal Chemotherapy for Stage III Colorectal Cancer.
   Am J Clin Oncol. 2023 Mar 30. doi: 10.1097/COC.0000000000000980.
   PubMed     Abstract available
   
   
   January 2023
7. LIU J, Wang X, Sahin IH, Imanirad I, et al
   Tumor Response-speed Heterogeneity as a Novel Prognostic Factor in Patients With Metastatic Colorectal Cancer.
   Am J Clin Oncol. 2023 Jan 6. doi: 10.1097/COC.0000000000000972.
   PubMed     Abstract available
   
   
   
8. ABDEL-RAHMAN O, Ghosh S
   Impact of Time From Diagnosis to Treatment Start on the Outcomes of Patients With Nonmetastatic Anal Squamous Cell Carcinoma.
   Am J Clin Oncol. 2023;46:31-35.
   PubMed     Abstract available
   
   
   December 2022
9. KHAROFA JR, Yothers G, Kachnic LA, Ajani J, et al
   Use of the Toxicity Index in Evaluating Adverse Events in Anal Cancer Trials: Analysis of RTOG 9811 and RTOG 0529.
   Am J Clin Oncol. 2022;45:534-536.
   PubMed     Abstract available
   
   
   October 2022
10. YANG F, Hill J, Abraham A, Ghosh S, et al
    Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation.
    Am J Clin Oncol. 2022;45:405-409.
    PubMed     Abstract available
    
    
    September 2022
11. 
    Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy: Erratum.
    Am J Clin Oncol. 2022;45:404.
    PubMed    
    
    
    August 2022
12. LOU J, Kooragayala K, Williams JP, Sandilos G, et al
    The Early Impact of the COVID-19 Pandemic on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center.
    Am J Clin Oncol. 2022 Aug 19. pii: 00000421-990000000-00030.
    PubMed     Abstract available
    
    
    
13. HUI C, Baclay R, Liu K, Sandhu N, et al
    Rectosigmoid Cancer-Rectal Cancer or Sigmoid Cancer?
    Am J Clin Oncol. 2022;45:333-337.
    PubMed     Abstract available
    
    
    July 2022
14. CHRABASZCZ S, Rajeev R, Witmer HDD, Dhiman A, et al
    A Systematic Review of Conversion to Resectability in Unresectable Metastatic Colorectal Cancer Chemotherapy Trials.
    Am J Clin Oncol. 2022 Jul 15. pii: 00000421-990000000-00024.
    PubMed     Abstract available
    
    
    
15. REDDY AV, Safar B, Jia AY, Azad NS, et al
    Nonoperative Management Following Complete Response in Rectal Cancer After Short-course Radiation Therapy and Consolidation Chemotherapy: Clinical Outcomes and Quality of Life Measures.
    Am J Clin Oncol. 2022;45:298-305.
    PubMed     Abstract available
    
    
    June 2022
16. NELSON B, Tadesse DG, Sudhoff M, Wang K, et al
    Hematologic Toxicity Comparison of Intensity Modulated Proton Therapy and Intensity Modulated Radiation Therapy in Anal Cancer Patients.
    Am J Clin Oncol. 2022;45:264-267.
    PubMed     Abstract available
    
    
    April 2022
17. D'ANDREA E, Russi M, Pacilio M, Bilotta F, et al
    Yttrium-90 Radioembolization of Colorectal Cancer Liver Metastases: A Systematic Review of Clinical Evidence.
    Am J Clin Oncol. 2022;45:175-181.
    PubMed     Abstract available
    
    
    March 2022
18. MACBETH F, Treasure T
    The Biology and Systemic Treatments Influence Survival in Advanced Gastrointestinal Cancers While the Controlled Trial of Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) Found That Surgical Resection Could Only Have a Small If Any Effect.
    Am J Clin Oncol. 2022;45:135-136.
    PubMed    
    
    
    January 2022
19. ULANJA MB, Beutler BD, Antwi-Amoabeng D, Moody AE, et al
    Factors Affecting Inpatient Mortality and Length of Stay in Nonmetastatic Colorectal Cancer: Insights from the National Inpatient Sample.
    Am J Clin Oncol. 2022;45:14-21.
    PubMed     Abstract available
    
    
    
20. LUTSYK M, Turgeman I, Bar-Sela G
    Rapid Initiation of Neoadjuvant Chemoradiotherapy After Diagnosis is Associated With Improved Pathologic Response in Locally Advanced Rectal Cancer.
    Am J Clin Oncol. 2022;45:1-8.
    PubMed     Abstract available
    
    
    November 2021
21. PUNEKAR SR, Griffin MM, Masri L, Roman SD, et al
    Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer.
    Am J Clin Oncol. 2021 Nov 10. pii: 00000421-900000000-98524.
    PubMed     Abstract available
    
    
    October 2021
22. ALABRABA E, Gomez D
    Surveillance Following Hepatic Resection for Colorectal Liver Metastases in Elderly Patients: Systematic Review to Guide "When to Draw the Line".
    Am J Clin Oncol. 2021;44:552.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.